Dupilumab Shows Promising Results for Hair Regrowth in Pediatric Alopecia Areata, with No New Safety Concerns: Study Medha Baranwal17 Aug 2024 9:30 AM ISTUSA: A real-world, single-center observational study revealed that dupilumab significantly enhanced hair regrowth in pediatric patients with alopecia...
FDA approves oral deuruxolitinib for severe alopecia areata Dr. Kamal Kant Kohli29 July 2024 9:45 PM ISTThe US Food and Drug Administration (FDA) has approved oral selective inhibitor of Janus Kinases (JAK) JAK1 and JAK2 deuruxolitinib (Lesqselvi) 8 mg...
Sun Pharma gets USFDA nod for alopecia areata drug Leqselvi Ruchika Sharma26 July 2024 11:34 AM ISTLEQSELVI is a new, twice daily oral selective inhibitor of Janus Kinases (JAK) JAK1 and JAK2.
Researchers develop microneedle patch to reverse hair loss caused by autoimmune disease Dr. Kamal Kant Kohli10 Jun 2024 8:00 AM ISTAlopecia areata (AA) is an autoimmune disease characterized by hair loss, which occurs when T cells of the immune system mistakenly attack hair...
Topical STS-01 Hits Efficacy Endpoints in Mild to Moderate Alopecia patients in Phase 2 trial Dr. Kamal Kant Kohli5 Jun 2024 8:00 PM ISTSoterios Pharma, a privately held clinical-stage pharmaceutical company, today announced positive topline results from its randomised,...
Photobiomodulation offers safe and effective treatment for variety of skin conditions, says new research Medha Baranwal14 March 2024 11:45 PM ISTUSA: A recent medical education article published in the Journal of the American Academy of Dermatology reviews the various clinical applications of...
Study finds significant rise in alopecia areata after COVID-19 Medha Baranwal12 Jan 2024 7:15 PM ISTSouth Korea: A nationwide study involving more than half a million South Koreans revealed a significant increase in the incidence of alopecia areata...
Sun Pharma arm signs licensing agreement with Aclaris Therapeutics Ruchika Sharma6 Dec 2023 12:30 PM ISTThe agreement includes an upfront payment of USD 15 million, regulatory and commercial milestones, and royalties.
SPARC enters into an exclusive worldwide license agreement with Johns Hopkins University, IOCB for hair loss drug Ruchika Sharma3 Nov 2023 12:30 PM ISTSCD-153 is a first-in-class topical drug for the treatment of alopecia areata developed jointly by SPARC, JHU and IOCB.
Pfizer hair loss drug Litfulo approved in UK Ruchika Sharma2 Nov 2023 11:30 AM ISTAlopecia areata is a condition where the immune system attacks hair follicles and causes hair to fall out, often in clumps.
Oral tofacitinib, novel alternative treatment for resistant alopecia areata among children Medha Baranwal27 Oct 2023 10:30 AM ISTChina: New research has demonstrated the safety and effectiveness of oral tofacitinib as a treatment option for pediatric alopecia areata (AA),...
USFDA accepts Sun Pharma NDA for alopecia areata drug Deuruxolitinib Ruchika Sharma6 Oct 2023 1:52 PM ISTMumbai: Sun Pharmaceutical Industries Ltd has announced that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application...
